Is OxiGene The Cheapest Biotech On The Nasdaq?
March 31, 2015 at 12:40 PM EDT
OxiGene, a small and virtually unknown biotech stock on the Nasdaq, boasts an impressive pipeline, yet the stock now trades at exactly cash level after a major sell-off. With multiple near-term catalysts in sight, I think shares could rebound hard.
